Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association
| Autor: | Thomas J Papadimos, Scott M. Pappada, Mark Dziuba, Hallie Hanna Dolin |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Thrombotic thrombocytopenic purpura
lcsh:Medicine Case Report Case Reports 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Antiphospholipid syndrome immune system diseases medicine thrombotic thrombocytopenic purpura Autoimmune disease lcsh:R5-920 Thrombospondin business.industry ADAMTS lcsh:R Autoantibody General Medicine medicine.disease Thrombosis ADAMTS13 030220 oncology & carcinogenesis Immunology lcsh:Medicine (General) business antiphospholipid syndrome disintegrin‐like and metalloprotease |
| Zdroj: | Clinical Case Reports Clinical Case Reports, Vol 7, Iss 10, Pp 1984-1988 (2019) |
| ISSN: | 2050-0904 |
| Popis: | Antiphospholipid syndrome (APS) is an autoimmune disease that demonstrates antiphospholipid antibodies that cause hypercoagulability and leads to venous and arterial thrombosis. Autoantibodies to a disintegrin‐like and metalloprotease with thrombospondin type I motif, member 13 (ADAMTS 13) play a role in the microthrombosis of thrombotic thrombocytopenic purpura in APS patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |